Now showing items 1-6 of 6
Skin autofluorescence and all-cause mortality in stage 3 CKD.
BACKGROUND AND OBJECTIVES: Novel markers may help to improve risk prediction in CKD. One potential candidate is tissue advanced glycation end product accumulation, a marker of cumulative metabolic stress, which can be ...
Acute kidney: improving the pathway of care for patients and across healthcare.
PURPOSE OF REVIEW: Acute kidney injury (AKI) is common, harmful and of global concern. There is a need to understand the pathway of the management of AKI in order to identify potential areas where care can be improved, for ...
The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study.
BACKGROUND: Multimorbidity is a growing concern for healthcare systems, with many countries experiencing demographic transition to older population profiles. Chronic kidney disease (CKD) is common but often considered in ...
Defining the cause of death in hospitalised patients with acute kidney injury.
BACKGROUND: The high mortality rates that follow the onset of acute kidney injury (AKI) are well recognised. However, the mode of death in patients with AKI remains relatively under-studied, particularly in general ...
A simple care bundle for use in acute kidney injury: a propensity score matched cohort study.
BACKGROUND: Consensus guidelines for acute kidney injury (AKI) have recommended prompt treatment including attention to fluid balance, drug dosing and avoidance of nephrotoxins. These simple measures can be incorporated ...
Understanding the scale of non-adherence with haemodialysis
Non-adherence significantly impacts patient care and outcomes, and has been associated with increased mortality. In this article, Kelly White and Richard Fluck discuss the results of a recent study into why dialysis sessions ...